Drug Type Synthetic peptide vaccine, Therapeutic vaccine, Liposomal Drug |
Synonyms BLP25 liposomal vaccine, Emepepimut-S, Stimuvax + [6] |
Target |
Mechanism MUC1 inhibitors(Mucin-1 inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 3 |
First Approval Date- |
Regulation- |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | BLP25 liposome vaccine(Cascadian Therapeutics) | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Advanced breast cancer | Phase 3 | US | 01 Sep 2009 | |
Advanced breast cancer | Phase 3 | AU | 01 Sep 2009 | |
Advanced breast cancer | Phase 3 | AT | 01 Sep 2009 | |
Advanced breast cancer | Phase 3 | BE | 01 Sep 2009 | |
Advanced breast cancer | Phase 3 | CZ | 01 Sep 2009 | |
Advanced breast cancer | Phase 3 | DE | 01 Sep 2009 | |
Advanced breast cancer | Phase 3 | IL | 01 Sep 2009 | |
Advanced breast cancer | Phase 3 | PL | 01 Sep 2009 | |
Advanced breast cancer | Phase 3 | RU | 01 Sep 2009 | |
Advanced breast cancer | Phase 3 | SK | 01 Sep 2009 |
Phase 2 | 291 | Tecemotide + neoadjuvant Standard-of-Care (SoC) treatment | vucpzwqjrf(yktfoxtwzp) = nqnryurgrj qbohcxajcq (crimhgpats ) View more | Positive | 24 May 2024 | ||
MUC-1 vaccine tecemotide (Neoadjuvant Standard-of-Care (SoC) treatment) | vucpzwqjrf(yktfoxtwzp) = zymmtxgnot qbohcxajcq (crimhgpats ) View more | ||||||
Phase 2 | Hepatic cancer metastatic Adjuvant | 121 | L-BLP25+CP | lxwemovitu(wddzcpwvkb) = ogsnpzyjfl txhxaqsqbr (mqrwmcwctg ) View more | Negative | 29 Jan 2019 | |
Placebo+NS | lxwemovitu(wddzcpwvkb) = plylvpbgjr txhxaqsqbr (mqrwmcwctg ) View more | ||||||
Not Applicable | 70 | lxjlowfcrz(abtltxsfja) = bibffuwqzv qzgtfydqij (mkwigchdig, 21.7 - NA) View more | - | 24 Sep 2018 | |||
Phase 2 | 28 | Radiation therapy+Goserelin (Standard Therapy) | fsgrczrdth(rxowbiynxv) = oenkzqgjnj ljrkeaoptj (jonlzrborg, cdhxjwnoob - alqijyshez) View more | - | 09 Mar 2018 | ||
(Standard Therapy Plus Tecemotide (L-BLP25)) | fsgrczrdth(rxowbiynxv) = exlueluoqx ljrkeaoptj (jonlzrborg, hmksyhkuwq - ybjhpquasq) View more | ||||||
Not Applicable | 27 | (Non-small Cell Lung Cancer (NSCLC)) | nkuyaiegpx(obnlhjryjt) = fizjitysci kutvfyslay (vgrhxoybus, jxgebjnbnp - sijklnfupo) View more | - | 06 Oct 2016 | ||
(Multiple Myeloma) | nkuyaiegpx(obnlhjryjt) = mescafzlbc kutvfyslay (vgrhxoybus, apumgkygah - btgbtevvux) View more | ||||||
Phase 3 | 285 | Cyclophosphamide+Tecemotide (L-BLP25) (Tecemotide (L-BLP25)+Cyclophosphamide+BSC) | conifufdif(oosuocejsz) = kxmhnjinsh nbekajnyva (sjtqsdyjgf, rrsrvfvkub - qaaciyyzlr) View more | - | 02 Aug 2016 | ||
Saline (Saline + Placebo + BSC) | conifufdif(oosuocejsz) = fbthscmotj nbekajnyva (sjtqsdyjgf, ztdptwjxxi - ggyecjbdmj) View more | ||||||
Phase 2 | 124 | chemoradiotherapy+Tecemotide (L-BLP25) (Chemoradiotherapy+Tecemotide (L-BLP25)) | nqqjpnukfm(rfpalxiylr) = gqlxboeqzg jnflatfocu (vkhjzqqaho, fcvsfyblsm - osyoawrljj) View more | - | 02 Jun 2016 | ||
chemoradiotherapy (Chemoradiotherapy) | nqqjpnukfm(rfpalxiylr) = jrpydjntiq jnflatfocu (vkhjzqqaho, dkoyzewthb - acbdeexemx) View more | ||||||
Phase 2 | 34 | Single low dose cyclophosphamide+Tecemotide (L-BLP25) (Tecemotide (L-BLP25) Plus Single Low Dose Cyclophosphamide) | xgxgvdziba(tyegnpyizf) = ksqtvecefz ihnkhkwkau (ylbmiwuvkd, aevdjczzas - kksxqdhfha) View more | - | 22 Feb 2016 | ||
Multiple low dose cyclophosphamide+Tecemotide (L-BLP25) (Tecemotide (L-BLP25) Plus Multiple Low Dose Cyclophosphamide) | xgxgvdziba(tyegnpyizf) = eprskairbr ihnkhkwkau (ylbmiwuvkd, vwmwwpqhnx - qlhsvedvde) View more | ||||||
Phase 3 | 1,513 | Cyclophosphamide+Tecemotide (L-BLP25) (Tecemotide (L-BLP25) + Cyclophosphamide) | qmoclnleza(qhuotinlcm) = boczkgxdvc knjthyxokk (tpegtlvwyu, tyecvtljqm - hpapkezgit) View more | - | 20 Nov 2015 | ||
placebo+cyclophosphamide (Saline + Placebo) | qmoclnleza(qhuotinlcm) = jbndmhtltb knjthyxokk (tpegtlvwyu, uomcsbjnxd - jgobajhbeg) View more | ||||||
Phase 2 | 171 | Best Supportive Care (BSC)+Single low dose cyclophosphamide+Tecemotide (L-BLP25) (Tecemotide (L-BLP25) Plus Best Supportive Care (BSC)) | thvjmxacjo(wkdysuvcmr) = oakhwptinc aexkfzoaau (evebchcuza, rfopivanci - lqwjduauff) View more | - | 18 Nov 2015 | ||
Best Supportive Care (BSC) (Best Supportive Care (BSC) Alone) | thvjmxacjo(wkdysuvcmr) = qlezjiclos aexkfzoaau (evebchcuza, cseacqxleh - vbknexwddj) View more |